Evidence map›Paper›PMID 36661060›Full record

ArticleJournal of medical virology2023

Torque teno virus (TTV): A gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients.

Piergiorgio Roberto, Lilia Cinti, Anna Napoli, Daniele Paesani, Rodolfo J Riveros Cabral, Fabrizio Maggi, Manuela Garofalo, Renzo Pretagostini, Anastasia Centofanti, Carolina Carillo and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Assessment ofInternational journal of molecular sciences · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Piergiorgio RobertoDepartment of Molecular Medicine, Laboratory of Microbiology and Virology, Sapienza University of Rome, Rome, Italy.
Lilia CintiDepartment of Molecular Medicine, Laboratory of Microbiology and Virology, Sapienza University of Rome, Rome, Italy.
Anna NapoliDepartment of Molecular Medicine, Laboratory of Microbiology and Virology, Sapienza University of Rome, Rome, Italy.
Daniele PaesaniINFN Frascati National Laboratory, Frascati, Italy.
Rodolfo J Riveros CabralDepartment of Molecular Medicine, Laboratory of Microbiology and Virology, Sapienza University of Rome, Rome, Italy.
Fabrizio MaggiLaboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Manuela GarofaloGeneral Surgery and Organ Transplantation Unit, Sapienza University of Rome, Rome, Italy.
Renzo PretagostiniGeneral Surgery and Organ Transplantation Unit, Sapienza University of Rome, Rome, Italy.
Anastasia CentofantiDepartment of General and Specialistic Surgery "Paride Stefanini", Sapienza University of Rome, Rome, Italy.
Carolina CarilloDepartment of General and Specialistic Surgery "Paride Stefanini", Sapienza University of Rome, Rome, Italy.
Federico VenutaDepartment of General and Specialistic Surgery "Paride Stefanini", Sapienza University of Rome, Rome, Italy.
Aurelia GaetaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Guido AntonelliDepartment of Molecular Medicine, Laboratory of Microbiology and Virology, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-2533-2939
Sapienza University of Rome · ITIstituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Frascati · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, no comprehensive marker to monitor the immune status of patients is available. Given that Torque teno virus (TTV), a known human virome component, has previously been identified as a marker of immunocompetence, it was retrospectively investigated whether TTV viral load may also represent a marker of ability to develop antibody in response to COVID-19-BNT162B2 vaccine in solid organ transplant recipients (SOT). Specifically, 273 samples from 146 kidney and 26 lung transplant recipients after successive doses of vaccine were analyzed. An inverse correlation was observed within the TTV copy number and anti-Spike IgG antibody titer with a progressive decrease in viremia the further away from the transplant date. Analyzing the data obtained after the second dose, a significant difference in TTV copy number between responsive and nonresponsive patients was observed, considering a 5 log

Indexed as

COVID-19DNA Virus InfectionsTorque teno virusBNT162 VaccineCOVID-19 VaccinesDNA, ViralHumansKidneyLungRetrospective StudiesSeroconversionTransplant RecipientsViral LoadBNT162 VaccineCOVID-19 VaccinesDNA, ViralBNT162B2 vaccinekidney transplantlung transplantSOT patientsTTV

Identifiers

PMID36661060
PMCPMC10108096
OpenAlexW4317567972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.